Digital therapautic effective in managing metabolic syndrome parameters

Abstract Introduction Lifestyle change is a class one therapeutic indication for persons with overweight, obesity, metabolic syndrome and cardiovascular risk factors including type II diabetes, hypertension dyslipidaemia. There synergism in reducing multiple cardiovacular simultaneously. Currently there need formalised prescribed digital to enact lifestyle optimally. We have developed real-time telemedicine these conditions substantive positive impact on weight, Body Mass Index (BMI), blood pressure (BP), parameters. Purpose To evaluate subjects parameters primary care, corporate pharmacy settings. Methods Cohorts of patients were enrolled through care physician referrals or settings; GDPR compliant format between 2015–2020 (n=323). The programme offers patient education, guideline dietary recommendations advice specific the requirements via smartphone, tablet computer. Nudge psychology educational videos, compliment exercise monitored by smart device weight loss recorded wireless scales. Point bloods tested pre post-enrollment. Asynchronous from dietician, peer support an artificial intelligence chat-bot are available at all times smartphone application. Statistics used was student two-tailed t-test comparing pretest those post intervention. Results Cohort results delineated below. As underwent refinement more added. Nevertheless similar trends seen each cohort statistically meaningful reductions BMI, systolic diastolic pressure, HbA1c lipids obtained. Reductions approach equate obtained using drug monotherapy. Moreover Quality Life improved. Conclusion A internet-based clinically lipids. various cohorts similar, indicating reproducible effect this cost effective scalable across spectrum variety Funding Acknowledgement Type funding sources: Private company. Main source(s): RedicareDiabetes Ireland Table 1